OraSure Technologies (OSUR) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue reached $54.3 million, near the top of guidance, with core revenue at $35.4 million and sequential improvement from new product launches.

• Fulfilled the largest COVID-19 contract with the U.S. government, generating $18.9 million in COVID-19 product revenue, though COVID-19 diagnostics sales fell 60% year-over-year.

• Achieved WHO prequalification for the OraQuick HCV self-test, the first hepatitis C self-test to receive this designation, and launched new FDA-cleared packaging for the OraQuick HIV self-test.

• Expanded partnerships in oncology and genetic testing, including agreements with Exact Sciences, Variantyx, and growth in saliva-based liquid biopsy.

• Cost efficiency and automation initiatives, workforce reductions, and business exits are driving productivity gains and restructuring.

Financial highlights

• Q2 2024 net revenues: $54.3 million, down 36% year-over-year; core revenues declined 7% to $35.4 million.

• GAAP gross margin improved to 45.4% from 30.9% year-over-year; non-GAAP gross margin was 47.4%.

• GAAP operating loss was $2.7 million, improved from $6.4 million last year; non-GAAP operating income was $3.3 million.

• Q2 2024 net loss was $0.6 million; GAAP EPS was $(0.01), non-GAAP EPS was $0.07.

• Cash, cash equivalents, and short-term investments totaled $267.4 million at quarter end; Q2 operating cash flow was $7.8 million.

Outlook and guidance

• Q3 2024 revenue guidance: $37–$41 million, with core revenue of $36–$39 million and InteliSwab revenue of $1–$2 million.

• Q3 gross margin expected in the low 40% range, returning to mid-40% in Q4; long-term gross margin target in the 50% range.

• Management expects continued declines in COVID-19 diagnostics revenue and minimal molecular services revenue as the business is exited.

• Existing cash and equivalents are expected to fund operations and capital expenditures over the next twelve months.

• Core revenue expected to moderate in Q4 due to seasonal patterns.